Update shared on07 Aug 2025
Fair value Increased 24%The increase in Beyond's consensus analyst price target from $8.80 to $10.90 is primarily driven by upward revisions in both revenue growth forecasts and future P/E multiples.
What's in the News
- Beyond, Inc. added to the Russell Microcap Value Benchmark Index, Russell 3000E Value Benchmark, Russell Microcap Value Index, Russell Microcap Index, Russell 3000E Value Index, and Russell 3000E Index.
- Beyond, Inc. updated its license agreement with Kirkland's, granting Kirkland's rights to operate Bed Bath & Beyond Home and buybuy BABY stores in neighborhood formats, increased their collaboration fee to 0.50% of brick-and-mortar revenue, and eliminated Kirkland’s prior 3% royalty on net sales from Bed Bath & Beyond and Overstock locations.
Valuation Changes
Summary of Valuation Changes for Beyond
- The Consensus Analyst Price Target has significantly risen from $8.80 to $10.90.
- The Consensus Revenue Growth forecasts for Beyond has significantly risen from 5.6% per annum to 6.7% per annum.
- The Future P/E for Beyond has significantly risen from 13.20x to 15.70x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.